These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25231545)

  • 1. The use of supersaturation for the vaginal application of microbicides: a case study with dapivirine.
    Grammen C; Plum J; Van Den Brande J; Darville N; Augustyns K; Augustijns P; Brouwers J
    J Pharm Sci; 2014 Nov; 103(11):3696-3703. PubMed ID: 25231545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
    Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
    Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients.
    Grammen C; Augustijns P; Brouwers J
    Antiviral Res; 2012 Nov; 96(2):226-33. PubMed ID: 23000496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
    Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide.
    Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD
    Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.
    Brouwers J; Vermeire K; Grammen C; Schols D; Augustijns P
    Antiviral Res; 2011 Aug; 91(2):217-23. PubMed ID: 21683096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitor.
    Zhang W; Parniak MA; Sarafianos SG; Cost MR; Rohan LC
    Int J Pharm; 2014 Jan; 461(1-2):203-13. PubMed ID: 24333452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Application of Hot Melt Extrusion for the Manufacturing of Vaginal Films Containing Microbicide Candidate Dapivirine.
    Regev G; Patel SK; Moncla BJ; Twist J; Devlin B; Rohan LC
    AAPS PharmSciTech; 2019 Jun; 20(6):239. PubMed ID: 31243640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
    Akil A; Devlin B; Cost M; Rohan LC
    Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.
    Nuttall JP; Thake DC; Lewis MG; Ferkany JW; Romano JW; Mitchnick MA
    Antimicrob Agents Chemother; 2008 Mar; 52(3):909-14. PubMed ID: 18086845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention.
    Dezzutti CS; Yandura S; Wang L; Moncla B; Teeple EA; Devlin B; Nuttall J; Brown ER; Rohan LC
    Pharm Res; 2015 Nov; 32(11):3768-81. PubMed ID: 26078001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels.
    Zidan AS; Habib MJ
    J Pharm Sci; 2014 Mar; 103(3):952-64. PubMed ID: 24464823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors.
    Madsen CM; Boyd B; Rades T; Müllertz A
    Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring.
    McCoy CF; Murphy DJ; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK
    J Pharm Sci; 2017 Aug; 106(8):2015-2025. PubMed ID: 28456732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MTN-033: a Phase 1 Study Comparing Applicator versus "as Lubricant" Delivery of Rectal Dapivirine Gel.
    Ho K; Dominguez-Islas C; Szydlo D; Edick S; Macagna N; Riddler SA; Brand RM; Jacobson CE; Kramzer L; Kunjara Na Ayudhya RP; Piper J; Marzinke MA; Bauermeister J; Nuttall J; Hillier SL; Hendrix CW
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0081622. PubMed ID: 36255254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine.
    das Neves J; Michiels J; Ariën KK; Vanham G; Amiji M; Bahia MF; Sarmento B
    Pharm Res; 2012 Jun; 29(6):1468-84. PubMed ID: 22072053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action.
    Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK
    Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.